Background. Gut ischaemia may contribute to morbidity in patients after cardiopulmonary bypass (CPB), but little is known about the metabolic state of the large bowel in such patients. Therefore we estimated the concentrations of L-lactate and PCO 2 in rectal mucosa in patients undergoing cardiac surgery with or without the use of CPB.
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Cardiopulmonary bypass (CPB) is associated with endotoxaemia and systemic inflammation, which suggests that gut ischaemia may contribute to morbidity in patients undergoing this procedure. 1 Previous studies have assessed potential gut ischaemia by tonometry and have demonstrated increased Pco 2 in the gastric lumen of patients during CPB. Thus increased gastric carbon dioxide may predict the development of postoperative complications in these patients. 2 3 A vast amount of endotoxin is localized in the large bowel, but no studies have assessed markers of metabolism in this part of the gut in patients undergoing CPB.
Luminal equilibrium dialysis is a valid non-invasive method for the estimation of extracellular concentrations of small molecules in rectal mucosa. 4 Moreover, previous studies in animals with occlusive gut ischaemia and in patients with septic shock have shown that measurements of lactate by luminal dialysis may be a method of assessing metabolic dysfunction in intestinal mucosa. [5] [6] [7] [8] The aim of the present study was to measure concentrations of L-lactate and Pco 2 in the rectal lumen in patients undergoing cardiac surgery with or without the use of CPB.
Methods and results

Participants
We studied consecutive patients undergoing coronary arterial bypass grafting (CABG) and normothermic CPB or off-pump CABG after approval by the regional ethics committee and informed written consent. The surgeon decided whether or not CPB was to be used based on the anatomy of the coronary lesions. In the off-pump CABG group, only patients expected to have two or more grafts were included in an attempt to match the time of anaesthesia in the two groups of patients. We did not include patients in whom a complicated perioperative course was expected (Euroscore >6 or left ventricular ejection fraction <30%) or patients with abnormal rectum or colon, inflammatory bowel disease or any gastrointestinal symptoms within the preceding month. Patients who had taken nonsteroidal anti-inflammatory drugs within the previous week or had excessive alcohol consumption were also excluded. Ten healthy volunteers from a previous study served as controls. 5 
Anaesthesia
Patients received diazepam 10-15 mg orally 1 h prior to induction. Anaesthesia was induced with fentanyl 10 mg kg À1 and midazolam 2-5 mg. Tracheal intubation was facilitated by pancuronium 0.1 mg kg À1 , and anaesthesia was maintained with isoflurane (0.5-1.0%) and fentanyl 2.5-5 mg kg À1 h À1 . The patients in the CPB group received 500 ml isotonic saline. The off-pump CABG group received isotonic saline and 6% dextran 70 in saline (Macrodex Ò , Pharmacia-Upjohn, Uppsala, Sweden). In the intensive care unit (ICU), all patients were sedated with an infusion of propofol (100-250 mg h À1 ) during the study.
Treatment with vasoactive drugs
Hypotension prior to CPB (mean arterial pressure [MAP] <60 mm Hg) was treated with i.v. ephedrine 5 mg or i.v. phenylephrine 0.1 mg depending on the heart rate. Hypotension during CPB (MAP <50 mm Hg) was treated with increased flow; if this was ineffective, phenylephrine was administered in i.v. boluses of 0.1 mg. Post-CPB hypotension (MAP <60 mm Hg) was treated with infusion of 500 ml dextran 70 and dopamine 2-10 mg kg À1 min À1 . In the off-pump CAGB group, hypotension (MAP <60 mm Hg) was treated with 500 ml dextran 70; if this was ineffective, phenylephrine was administered in i.v. boluses of 0.1 mg. The latter was supplemented by dopamine 2-10 mg kg À1 min À1 if several doses had to be given. Perioperative hypertension (MAP >90 mm Hg) was treated by either increasing the depth of anaesthesia or infusion of nitroglycerin.
Cardiopulmonary bypass
Normothermic non-pulsatile CPB, using a membrane oxygenator and flow of 2.4 litre min À1 m À2 , was provided by a heart-lung machine primed with Ringer's lactate, which contains L-lactate 28 mmol litre À1 . Cardiac arrest was induced by antegrade blood cardioplegia and distal grafting was performed during complete aortic clamping.
Study protocol
L-Lactate concentrations and Pco 2 in the rectal lumen were measured by equilibrium dialysis as previously described. 5 After the induction of anaesthesia, a 12 cm long bag of dialysis tubing (semipermeable cellulose, cut-off 12 kDa) (Sigma, St Louis, MO, USA) was placed in the rectal lumen. The bag was filled with 4 ml of 10% dextran 40 in isotonic saline (Rheomacrodex Ò , MEDA, Solna, Sweden) and closed over 5 cm of Tygon Ò tube (Cole-Parmer Instruments Company, Vernon Hills, IL, USA) with a three-way stopcock at the distal end to allow airtight sampling. At the end of the procedure the dialysate was sampled and the bag was removed. Dialysis for 4 h is required to ensure full equilibrium in the rectal lumen. 4 In two CABG and three off-pump CABG patients, the procedure lasted <4 h, and so 10-20 min of the postoperative period was included in the time of equilibration in these patients. Upon arrival in the ICU, a new bag was placed and another full equilibrium dialysis was performed during the first 4 h after the operation. Arterial blood samples were taken before anaesthesia and every hour during the study. L-Lactate concentrations and Pco 2 in dialysates and arterial blood were measured by autoanalyser (ABL 725, Radiometer, Copenhagen, Denmark). The healthy subjects were subjected to a single rectal equilibrium dialysis of 4 h.
In vitro equilibration
Dialysis bags were incubated for 0.5-4 h in saline baths containing 1 mmol litre À1 L-lactate (Sigma) or 5% carbon dioxide (AGA, Copenhagen, Denmark) at 37 C (n=5). Dialysates were analysed as described above. The median (range) dialysate values of L-lactate reached 50 (33-56)%, 78 (54-78)%, 89 (75-100)% and 100 (88-100)% equilibrium at 0.5 h, 1 h, 2 h and 4 h, respectively. The equivalent values for Pco 2 were 91 (89-93)%, 98 (93-101)%, 101 (99-104)% and 105 (103-108)%.
Statistics
Data are presented as median (range) and analysed using the Mann-Whitney or Wilcoxon tests or Spearman's rank correlation test where appropriate (GraphPad Prism v. 4.00, GraphPad Software, San Diego, CA, USA). P-values <0.05 (two-tailed) were considered significant. The sample size was not calculated prior to the study, but we have previously detected clinically relevant differences in sepsis using similar numbers of patients and controls. 5 
Results
The patient characteristics and the procedures undertaken are shown in Table 1 . All patients had an uneventful perioperative course. In the CPB group, five patients were treated with phenylephrine 0.1-1.5 mg during CPB and six patients required dopamine 4-6 mg kg À1 min À1 when
Increased L-lactate in rectal mucosa during CPB coming off CPB, and this was continued after the operation in two of these patients. In the off-pump CAGB group, three patients were treated with dopamine 2-6 mg kg À1 min À1 during grafting, which was continued after the operation in one of these patients.
The luminal concentrations of L-lactate were 2-to 3-fold higher in patients undergoing CPB than in patients undergoing off-pump CABG and healthy subjects (Fig. 1) . During CPB, the luminal concentrations of L-lactate were higher than the mean concentrations in arterial blood (Fig. 1) , and the two values were positively correlated (Fig. 2) .
The luminal values of L-lactate remained elevated 4 h after the operation (Fig. 1 ). There were no significant differences in luminal values of L-lactate between patients who were treated with dopamine for post-CPB hypotension (n=6), and those who came off CPB without dopamine (n=6) (during surgery 3.3 (0.7-4.9) vs 1.5 (0.9-3.1) mmol litre À1 , P=0.13; in the ICU 1.8 (0.5-6.0) vs 1.0 (0.5-3.0) mmol litre À1 , P=0.39). In the off-pump CABG patients, the luminal concentrations of L-lactate were also increased during and after the procedure and the luminal L-lactate concentrations were higher than the mean values in arterial blood (Fig. 1) .
Luminal Pco 2 was the same in all groups of patients and controls and substantially higher than the mean values observed in arterial blood (Fig. 3) . There was no difference in the luminal-arterial Pco 2 gradient between the groups of patients (Fig. 3) .
Discussion
The data obtained show that the use of CPB is associated with increased concentrations of L-lactate in the rectal lumen in patients during and after cardiac surgery, implicating moderate but sustained metabolic dysfunction of the mucosa. The high lumen-to-blood gradient of L-lactate indicates that luminal L-lactate is produced in the mucosa rather than spilled over from the blood. This is substantiated by data from animal studies of systemic lactate clamp, where luminal lactate was minimally affected by severe hyperlactataemia (>6 mmol litre À1 ). 6 Priming of the heart-lung machine with Ringer's lactate has been shown to increase the systemic concentrations of lactate by 35%, which was observed immediately after the establishment of CPB and lasted no more that 40 min. 9 In contrast, we observed a much higher increase in luminal values, which was prolonged into the postoperative period. Therefore it is unlikely that the Ringer's lactate used for priming contributed to our observation of increased luminal L-lactate. The correlation between the luminal and systemic values in the present study suggests that the production of L-lactate in gut mucosa contributes to the hyperlactataemia observed in these patients. Alternatively, a common cause exists for the increased concentrations of L-lactate. This could be generalized vascular dysfunction, but it is currently not known whether increased luminal concentration of L-lactate indicates bowel ischaemia. Epinephrine may cause systemic lactic acidosis through aerobic glycolysis, 10 but to our knowledge this has not been shown for phenylephrine or dopamine, which were the sympathomimetics used in the present study.
From a theoretical point of view, metabolic dysfunction of the gut in patients undergoing CPB is better assessed in the large bowel, which contains most of the bacteria and endotoxins. As previous studies of this matter have measured gastric pH or Pco 2 , future studies should include luminal measurements of gastric Pco 2 and L-lactate.
The increased concentration of L-lactate in the rectal lumen during and after the off-pump CABG procedure indicates metabolic dysfunction in the mucosa in these patients, albeit to a lesser degree than in patients subjected to CPB. This is not surprising as the patients were old and had undergone major surgery. It is unlikely that this difference in luminal L-lactate was clinically relevant because all patients had an uneventful perioperative course. However, we can speculate that this might make a difference to patients with lower cardiovascular reserves.
The high values of Pco 2 in the rectal lumen of patients are within the range previously observed in patients with septic shock. 5 As the values were equally raised in healthy subjects, luminal carbon dioxide in the rectum may originate from bacterial metabolism. Alternatively, acids in faeces may be buffered by bicarbonate ions, which are secreted into the lumen by epithelial cells. Consequently, any change in bacterial metabolism or epithelial secretion of bicarbonate ions could affect Pco 2 and complicate the interpretation of these values. On the other hand, changes in luminal-arterial carbon dioxide difference, as detected by gas tonometry in the sigmoid colon during surgery, may predict complications in patients undergoing repair of abdominal aortic aneurysm. 11 It is currently not known whether Pco 2 in the rectum is higher than in the sigmoid colon, but the Pco 2 values observed in the rectum in our healthy subjects were within the range of those observed in the sigmoid colon during aortic repair. 11 12 Taken together, it is unlikely that the measurement of luminal Pco 2 in the rectum is a useful marker of regional flow or metabolism. Luminal bacteria may also generate lactate, but these produce the D-isoform, which is not detected by the auto-analyser used in the present study. 5 However, systemic concentrations of D-lactate have been suggested to be a marker of metabolic dysfunction of the large bowel in critically ill patients. 13 The elimination kinetics of this isoform in humans, 14 including the influence of critical illness, need to be established before this simple measure can be used to assess the metabolic state of the colonic mucosa.
Luminal dialysis in the rectum has the potential to be used clinically to estimate mucosal concentrations of L-lactate. This is substantiated by observations in patients with septic shock, where luminal values of L-lactate correlated with mucosal permeability in the large bowel. 15 Future studies of patients on CPB should address these matters, as well as the effects of fluid management and different vasoactive drugs.
In summary, uncomplicated normothermic CPB is associated with a moderate but sustained increase in luminal concentrations of L-lactate in the rectum, indicating metabolic dysfunction of the mucosa. In contrast, luminal Pco 2 in the rectum was equally raised in patients and healthy subjects, questioning its use as a marker of metabolism. It can be speculated that mucosal ischaemia of the large bowel contributes to the endotoxaemia observed with the use of CPB. 
